Fundraising Fox
/People
Sign in

Nihal Sinha

Investor

Partner at F-Prime Capital

London

Writes $100K – $10M checks · typically $5M

Find your path to Nihal

601 people in our graph can introduce you to Nihal.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Kush M Parmar to introduce you to Nihal

You →Kush · together at Ensoma (2023–2026) →Nihal

Ask Jamie Chen to introduce you to Nihal

You →Jamie · 2 people · together at Orchard Therapeutics →Nihal

Ask Sam Okafor to introduce you to Nihal

You →Sam · 9 people · together at F-Prime Capital →Nihal

Sign up to find every way you can get introduced to Nihal

  • Your email: the people you already email who know Nihal
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Nihal
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Contact· self-published, not guessed

Experience

  1. F-Prime CapitalPartnercurrent2014 — presentLondon, United Kingdom
  2. ImmutrinBoard Directorcurrent2026 — presentCambridge
  3. T-Therapeutics LtdBoard Directorcurrent2023 — presentCambridge, England, United Kingdom
  4. CHARM TherapeuticsBoard Director, Founding Investorcurrent2021 — present
  5. EnsomaBoard Directorcurrent2023 — presentBoston, Massachusetts, United States
  6. AviadoBioBoard Directorcurrent2020 — presentLondon, England, United Kingdom
  7. Orchard TherapeuticsFounding Team2016 — 2019London, United Kingdom
  8. Fidelity BiosciencesAnalyst2013 — 2014
  9. The Boston Consulting GroupManagement Consultant2012 — 2013London, United Kingdom
  10. OXFORD UNIVERSITY HOSPITALS NHS TRUSTAcademic Clinical Fellow2010 — 2012Oxford, United Kingdom
  11. University of CambridgeNeuroscience Supervisor2005 — 2012
  12. NHSDoctor2008 — 2012
  13. University College London Hospitals NHS Foundation TrustAcademic Foundation Programme in Neurology2008 — 2010

Skills & more

Venture Capital50Healthcare62Life Sciences51Science21Neuroscience23Strategy18Clinical Research16Lifesciences13Management Consulting9Medicine12Entrepreneurship9Biotechnology14
+4 moreStart-upsBusiness DevelopmentLeadershipProject Management

From Nihal's professional profile.

Deals · 1

Antlia Bioscience, Inc.Board seat

via F-Prime Capital · filed Jun 2026 · $20M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: SEC Form D filings · curated public sources.

Colleagues at F-Prime Capital

Abby Wagner
Senior Accountant at F-Prime Capital Partners
Abdul Abdirahman
Principal at F-Prime Capital Partners
Alex Pasteur
Partner at F-Prime Capital Partners
Alex Pasteur, PhD
Partner at F-Prime Capital
Allan Galper
Vice President & Associate General Counsel at F-Prime Capital Partners
Allison MacLeod
Venture Partner at F-Prime Capital Partners
Amber Cai
Venture Partner at F-Prime Capital Partners
Amber Cai, PhD
Venture Partner at F-Prime Capital

Frequently asked questions

Who is Nihal Sinha?
Partner at F-Prime Capital Partners
Where does Nihal Sinha work?
Nihal Sinha is Partner at F-Prime Capital.
What check size does Nihal Sinha write?
Nihal Sinha typically writes checks of $100K – $10M.
What boards does Nihal Sinha sit on?
Nihal Sinha holds tracked board seats at Antlia Bioscience, Inc., CHARM Therapeutics.
What companies has Nihal Sinha invested in?
Investments tracked here include AvenCell, CHARM Therapeutics, Elucidata, Immutrin, Rigimmune, T Therapeutics.
Where did Nihal Sinha go to school?
Nihal Sinha studied at University of Cambridge (MB BChir, Medicine); Royal College of Physicians (MRCP, Medicine); University of Cambridge (MA, Physiology and Psychology).

Same school

Shared employers